Enter assignee name

EPO Patents = 4

Forward Citations = 8

Loading Chart...

28 inventors (with patents filed for the assignee):

Stephen Paul Hale (2 out of 12 patents)

Benjamin A Seigal (2 out of 4 patents)

Nicholas K Terrett (2 out of 2 patents)

4. Timothy F Briggs (2 out of 2 patents)

5. Frank G Favaloro, Jr (2 out of 2 patents)

6. James M Coull (2 out of 46 patents)

7. Li Huang Xing (1 out of 25 patents)

8. Joshua A Bittker (1 out of 4 patents)

9. Jinbo Lee (1 out of 24 patents)

10. Atli Thorarensen (1 out of 26 patents)

11. Yong Zhang (1 out of 30 patents)

12. Kelley C Shortsleeves (1 out of 7 patents)

13. Andrew W Fraley (1 out of 13 patents)

14. Michael Taylor (1 out of 1 patent)

15. William H Connors (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 9605022 - Macrocyclic compounds for inhibition of inhibitors of apoptosis (2017-03-28),

2. 9284283 - Macrocyclic compounds for modulating IL-17 (2016-03-15),

3. 8338565 - Macrocyclic compounds for inhibition of tumor necrosis factor alpha (2012-12-25),

4. 8071388 - Compositions and methods for biodetection by nucleic acid-templated chemistry (2011-12-06),

5. 7968289 - Turn over probes and use thereof for nucleic acid detection (2011-06-28),

Ensemble Therapeutics Corporation is a biotechnology company that is focused on the discovery and development of novel therapeutics using its proprietary drug discovery platform. The company's platform enables the rapid discovery of small molecule medicines for a wide range of diseases including cancer, infectious diseases, and inflammation. Ensemble Therapeutics Corporation is dedicated to improving patient outcomes through innovative drug discovery approaches.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

5 Patents

#336 in Cambridge, MA

#2,814 in Massachusetts

#50,178 in US

Cambridge, MA, United States of America

Ensemble Therapeutics Corporation